Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2000
11/15/2000CN1273584A Imidazolyl-cyclic acetals
11/15/2000CN1058490C Tetrazolinone derivatives
11/14/2000US6147253 N-protected/N-substituted-beta-amino-hydroxy sulfonates
11/14/2000US6147105 Use in the treatment of estrogen-related diseases
11/14/2000US6147083 Novel substituted 1,2-ethanediamine derivatives which antagonize the pharmacological actions of the endogenous neuropeptide tachykinins known as neurokinins, useful for the treatment of asthma, etc.
11/09/2000WO2000066581A1 Cyanopyrroles as progesterone receptor agonists
11/09/2000WO2000066568A1 Pesticidal triazine derivatives
11/09/2000WO2000066567A1 Pyrimidinone compounds
11/09/2000WO2000066566A1 Pyrimidine compounds
11/09/2000WO2000066563A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands
11/09/2000WO2000066556A1 Indoline derivatives as progesterone antagonists
11/09/2000WO2000066551A1 Cyclic amide compounds, process for the preparation of the same and uses thereof
11/09/2000WO2000066120A1 Novel catechols as antimicrobial agents
11/09/2000WO2000066119A1 Novel prolines as antimicrobial agents
11/09/2000WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
11/09/2000WO2000066106A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
11/09/2000WO2000039087A3 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000WO2000035906A3 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
11/09/2000DE19922443A1 Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen Use of dopamine D3 receptor ligands for the preparation of drugs for the treatment of renal dysfunction
11/09/2000DE19920936A1 Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung Heterocyclic substituted benzimidazoles, their preparation and application
11/09/2000CA2372176A1 Novel prolines as antimicrobial agents
11/09/2000CA2372079A1 Novel catechols as antimicrobial agents
11/09/2000CA2371671A1 Pyrimidinone compounds
11/09/2000CA2371638A1 Indoline derivatives as progesterone antagonists
11/09/2000CA2371629A1 3,3-substituted indoline derivatives
11/09/2000CA2371618A1 Cyclic amide compounds, their production and use
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049690A1 s-(2'-HYDROXYPHENYL) BENZOTRIAZOLES CONTAINING A 2,4-IMIDAZOLIDINEDIONE GROUP AND PROCESS FOR THEIR PREPARATION
11/08/2000EP0637307B1 Imidazole, triazole and tetrazole derivatives
11/08/2000EP0588917B1 Isoxazole and isothiazole compounds that enhance cognitive function
11/08/2000CN1272842A 2-acylaminopropanamines as tachykinin receptor antagonists
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1272493A Novel amino-triazole compound, its preparation method and drug composition containing them
11/07/2000US6143901 Complex formation between dsDNA and pyrrole imidazole polyamides
11/07/2000US6143892 Process for making 5-substituted pyrazoles
11/07/2000US6143886 Azepinone compounds useful in the inhibition of ACE and NEP
11/07/2000US6143762 Tetrahydroisoquinoline derivatives and their pharmaceutical use
11/07/2000US6143696 Substituted 4-(3-alkenylbenzoyl)pyrazoles
11/02/2000WO2000064891A1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof
11/02/2000WO2000064890A1 Herbicidal 3-(heterocycl-1-yl)-uracils
11/02/2000WO2000064889A1 Herbicidal 3-(heterocycl-1-yl)-uracils
11/02/2000WO2000064888A1 Di-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064885A1 Heteroaryl diazacycloalkanes, their preparation and use
11/02/2000WO2000064880A1 Selective npy (y5) antagonists
11/02/2000WO2000064878A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
11/02/2000WO2000064872A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK)
11/02/2000WO2000064864A1 N-protected amines and their use as prodrugs
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000EP1047693A1 Herbicides 3-(benzazol-4-yl)pyrimidine-dione-derivatives
11/02/2000EP1047690A1 Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission
11/02/2000EP0808312B1 Indole derivatives as 5-ht receptor antagonist
11/02/2000CA2371274A1 Selective npy (y5) antagonists
11/02/2000CA2368205A1 N-protected amines and their use as prodrugs
11/02/2000CA2367695A1 Heteroaryl diazacycloalkanes, their preparation and use
11/01/2000CN1272108A Indole derivatives as 5-HT1B and 5-HT1D agonists
10/2000
10/31/2000US6140352 Carbazolyl-substituted ethanolamines as selective β-3 agonists
10/31/2000US6140345 For treating psychoses and pain
10/31/2000US6140331 For treating anxiety disorders, depression, psychosis, impulse control disorders, alcohol abuse, ischaemic diseases, cardiovascular disorders, side effects induced by conventional antipsychotic agents and senile dementia
10/31/2000US6140326 Morpholinones as light stabilizers
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063195A1 Novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors
10/26/2000WO2000063187A1 Fab i inhibitors
10/26/2000WO2000063183A1 Process for the preparation of substituted pyrimidines
10/26/2000WO2000063171A1 Tricyclic compounds
10/26/2000WO2000063168A1 Synthesis of azetidine derivatives
10/26/2000WO2000039082A3 1,2-annelated quinoline derivatives
10/26/2000WO2000035886A3 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/26/2000DE19918211A1 New 2-carbocyclyl-benzimidazole-carboxamide derivatives, are PARP inhibitors useful e.g. for treating neurodegenerative disease, epilepsy, ischemia, tumors, inflammation or diabetes
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370285A1 Process for the preparation of substituted pyrimidines
10/25/2000EP1045846A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
10/25/2000EP1045843A1 Inhibitors of farnesyl-protein transferase
10/25/2000EP1045833A1 2,3-substituted indole compounds as cox-2 inhibitors
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/25/2000CN1271355A Heterocyclic compounds and antitumor agent containing the same as active ingredient
10/25/2000CN1271346A Method for producing substituted 2-nitroguanidine derivative
10/24/2000US6136834 Tetrazole compounds and pharmaceutical agents containing such derivative
10/24/2000US6136831 Pyrazole derivatives and COX inhibitors containing them
10/24/2000US6136812 Methods of administering AMPA receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
10/24/2000US6136344 Oral pharmaceutical dosage form
10/19/2000WO2000061687A1 Cyanine dye
10/19/2000WO2000061579A1 New endothelin converting enzyme inhibitors, their production and their use
10/19/2000WO2000061564A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
10/19/2000WO2000061563A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
10/19/2000WO2000061562A1 Neurotrophic substituted pyrimidines
10/19/2000WO2000061551A2 Pyrimidine-2-one derivatives as integrin receptor ligands
10/19/2000WO2000007996A8 Pyrazoles as estrogen receptor modulators
10/19/2000DE19916719A1 Neue ECE-Inhibitoren, ihre Herstellung und Verwendung New ECE inhibitors, their preparation and use
10/19/2000DE19916460A1 New heterocyclyl-benzimidazole carboxamide derivatives, useful for treating e.g. neurodegenerative diseases, epilepsy, ischemic damage, myocardial infarction, tumors, inflammation and diabetes
10/19/2000CA2368049A1 Integrin receptor ligands
10/18/2000EP1044970A1 Aminotriazole compounds, process for their preparation and pharmaceutical compositions containing them
10/18/2000EP1044969A2 Processes and intermediates for preparing anti-cancer compounds
10/18/2000EP1044199A1 Heterocyclic topoisomerase poisons
10/18/2000EP1044197A2 New piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/18/2000EP1044191A2 Benzylidene pyrazolones, production and use thereof
10/18/2000CN1270584A Morpholinones as light stabilizers
10/18/2000CN1270518A Therapeutic or prophylactic agent for glomerulopathy
10/18/2000CN1270166A Derivatives of tricyclo-substituted isohydroxyloxime acid
10/17/2000US6133452 Synthesis of bisindolylmalimides
1 ... 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 ... 626